85 related articles for article (PubMed ID: 8369382)
1. Qualitative interactions in multifactor studies.
Russek-Cohen E; Simon RM
Biometrics; 1993 Jun; 49(2):467-77. PubMed ID: 8369382
[TBL] [Abstract][Full Text] [Related]
2. Testing for qualitative interactions between treatment effects and patient subsets.
Gail M; Simon R
Biometrics; 1985 Jun; 41(2):361-72. PubMed ID: 4027319
[TBL] [Abstract][Full Text] [Related]
3. A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials.
Royston P; Sauerbrei W
Stat Med; 2004 Aug; 23(16):2509-25. PubMed ID: 15287081
[TBL] [Abstract][Full Text] [Related]
4. A treatment allocation procedure for sequential clinical trials.
Begg CB; Iglewicz B
Biometrics; 1980 Mar; 36(1):81-90. PubMed ID: 7370375
[TBL] [Abstract][Full Text] [Related]
5. Bayesian subset analysis.
Dixon DO; Simon R
Biometrics; 1991 Sep; 47(3):871-81. PubMed ID: 1742443
[TBL] [Abstract][Full Text] [Related]
6. Assessing time-by-covariate interactions in relative survival models using restrictive cubic spline functions.
Bolard P; Quantin C; Abrahamowicz M; Esteve J; Giorgi R; Chadha-Boreham H; Binquet C; Faivre J
J Cancer Epidemiol Prev; 2002; 7(3):113-22. PubMed ID: 12665210
[TBL] [Abstract][Full Text] [Related]
7. Testing for qualitative interactions between stages in an adaptive study.
Parker RA
Stat Med; 2010 Jan; 29(2):210-8. PubMed ID: 19908261
[TBL] [Abstract][Full Text] [Related]
8. Testing for crossover of two hazard functions using Gail and Simon's method.
Chen YH; Liu GH
J Biopharm Stat; 2006 May; 16(3):313-26. PubMed ID: 16724487
[TBL] [Abstract][Full Text] [Related]
9. A two stage conditional power adaptive design adjusting for treatment by covariate interaction.
Ayanlowo AO; Redden DT
Contemp Clin Trials; 2008 May; 29(3):428-38. PubMed ID: 18053774
[TBL] [Abstract][Full Text] [Related]
10. Minimization method for balancing continuous prognostic variables between treatment and control groups using Kullback-Leibler divergence.
Endo A; Nagatani F; Hamada C; Yoshimura I
Contemp Clin Trials; 2006 Oct; 27(5):420-31. PubMed ID: 16807130
[TBL] [Abstract][Full Text] [Related]
11. Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer.
Royston P; Parmar MK; Sylvester R
Stat Med; 2004 Mar; 23(6):907-26. PubMed ID: 15027080
[TBL] [Abstract][Full Text] [Related]
12. Detecting qualitative interactions in clinical trials: an extension of range test.
Li J; Chan IS
J Biopharm Stat; 2006; 16(6):831-41. PubMed ID: 17146982
[TBL] [Abstract][Full Text] [Related]
13. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
14. An alternative to the use of two-sided tests in clinical trials.
Dunnett CW; Gent M
Stat Med; 1996 Aug; 15(16):1729-38. PubMed ID: 8870155
[TBL] [Abstract][Full Text] [Related]
15. [Meta-analysis of the Italian studies on short-term effects of air pollution].
Biggeri A; Bellini P; Terracini B;
Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
[TBL] [Abstract][Full Text] [Related]
16. Analysis of two-period crossover design in a multicenter clinical trial.
Castellana JV; Patel HI
Biometrics; 1985 Dec; 41(4):969-77. PubMed ID: 3830261
[TBL] [Abstract][Full Text] [Related]
17. CrossOver: an algorithm for the construction of efficient cross-over designs.
John JA; Russell KG; Whitaker D
Stat Med; 2004 Sep; 23(17):2645-58. PubMed ID: 15316948
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in clinical cancer trials.
Estey E
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2591-3. PubMed ID: 9815662
[TBL] [Abstract][Full Text] [Related]
19. Design considerations in crossover trials with a single interim analysis and serial patient entry.
Cook RJ; Willan AR
Biometrics; 1996 Jun; 52(2):732-9. PubMed ID: 8672709
[TBL] [Abstract][Full Text] [Related]
20. [Treatment by drawing lots in a therapeutic trial with a balance distribution of prognostic factors: the minimization method].
Mollié A; Hill C
Rev Epidemiol Sante Publique; 1988; 36(2):138-43. PubMed ID: 3045921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
